COVID-19 pandemic in the Andaman and Nicobar Islands

• As on 23 May 2020, total number of cases in Andaman and Nicobar Islands was 33. There are no active cases, as all 33 have successfully recovered from the virus.[3]

• As on 11 June 2020, total number of cases in Andaman and Nicobar Islands was 38. There are 5 active cases and 33 have successfully recovered from the virus.[3]
• As on 23 June 2020, total number of cases in Andaman and Nicobar Islands was 50. There are 10 active cases and 40 have successfully recovered from the virus.[3]
• As on 26 June 2020, total number of cases in Andaman and Nicobar Islands was 72. There are 29 active cases and 43 have been cured.[3]
• As on 29 June 2020, total number of cases in Andaman and Nicobar Islands was 90. There are 45 active cases and 45 have been cured.[3]

• As on 3 July 2020, total number of cases in Andaman and Nicobar Islands was 116. There are 65 active cases and 51 have recovered.[3]
• As on 7 July 2020, total number of cases was 147. There are 73 active cases and 74 have recovered.[3]
• As on 15 July 2020, total number of cases in the UT was 176. There are 46 active cases and 130 have recovered.[3]
• As on 19 July 2020, total number of cases was 202. There are 57 active cases and 145 recoveries.[3]
• As on 26 July 2020, total number of cases was 317. There are 137 active cases and 180 cures.[3]

• As on 1 August 2020, total number of cases in Andaman and Nicobar Islands was 635. There are 402 active cases, 226 have recovered and 7 have succumed to the virus.[3]
• As on 5 August 2020, total number of cases was 928. There are 639 active cases, 277 have been cured and 12 have succumbed to the virus.[3]
• As on 8 August 2020, total number of cases was 1222. There are 778 active cases, 425 cures and 19 fatalities.[3]
• As on 12 August 2020, total number of cases in the UT was 1900. There are 1050 active cases, 829 have recovered and 21 deaths.[3]
• As on 18 August, total number of cases was 2529. There are 1078 active cases, 1421 cures and 30 deaths.[3]
• As on 23 August, total number of cases was 2860. There are 864 active cases, 1963 cures and 33 fatalities.[3]
• As on 25 August, total number of cases was 2945, including 677 active cases, 2231 recoveries and 37 fatalities.[3]

• As on 1 September 2020, total number of cases in Andaman and Nicobar Islands was 3160. There are 400 active cases, 2714 have recovered and 46 have died.[3]
• As on 2 September 2020, total number of cases in the UT was 3186. This includes 381 active cases, 2758 recoveries and 47 deaths.[3]
• As on 6 September 2020, total number of cases was 3332. This includes 331 active cases, 2951 recoveries and 50 deaths.[3]
• As on 7 September 2020, total number of cases was 3359, including 312 active cases, 2997 recoveries and 50 deaths.[3]
• As on 11 September 2020, total number of cases was 3494, including 286 active cases, 3157 cures and 51 deaths.[3]
• As on 12 September 2020, total number of cases was 3521, including 268 active cases, 3202 cures and 51 deaths.[3]
• As on 16 September 2020, total number of cases in the UT was 3593. This includes 196 active cases, 3345 recoveries and 52 deaths.[3]
• As on 19 September 2020, total number of cases was 3644, including 156 active cases, 3436 cures and 52 deaths.[3]
• As on 20 September 2020, total number of cases was 3651, including 148 active cases, 3451 recoveries and 52 deaths.[3]
• As on 21 September 2020, total number of cases was 3673, including 152 active cases, 3469 cures and 52 deaths.[3]
• As on 28 September 2020, total number of cases was 3803, including 168 active cases, 3582 recoveries and 53 deaths.[3]

• As on 2 October 2020, total number of cases in Andaman and Nicobar Islands was 3858. There are 174 active cases, 3631 have recovered and 53 have died.[3]
• As on 3 October 2020, total number of cases was 3868. There are 173 active cases, 3642 have recovered and 53 have died.[3]
• As on 4 October 2020, total number of cases was 3884. There are 182 active cases, 3649 cures and 53 fatalities.[3]
• As on 5 October 2020, total number of cases was 3899. There are 186 active cases, 3659 cures and 54 deaths.[3]
• As on 10 October 2020, total number of cases was 3992, including 193 active cases, 3744 recoveries and 55 deaths.[3]
• As on 13 October 2020, total number of cases was 4036, including 199 active cases, 3782 cures and 55 fatalities.[3]
• As on 19 October 2020, total number of cases was 4126, including 178 active cases, 3892 cures and 56 deaths.[3]
• As on 20 October 2020, total number of cases was 4141, including 183 active cases, 3902 recoveries and 56 deaths.[3]
• As on 25 October 2020, total number of cases in the UT was 4245, including 204 active cases, 3983 recoveries and 58 deaths.[3]
• As on 27 October 2020, total number of cases was 4274. There are 197 active cases, 4019 have recovered and 58 have died.[3]
• As on 30 October 2020, total number of cases was 4317. There are 182 active cases, 4076 have recovered and 59 deaths.[3]

• As on 8 November 2020, total number of cases in Andaman and Nicobar Islands was 4450. There are 169 active cases, 4221 recoveries and 60 have died.[3]
• As on 14 November 2020, total number of cases was 4527. There are 151 active cases, 4315 recoveries and 61 have died.[3]
• As on 23 November 2020, total number of cases was 4656, including 142 active cases, 4453 recoveries and 61 deaths.[3]
• As on 26 November 2020, total number of cases is 4682, including 130 active cases, 4491 recoveries and 61 fatalities.[3]
• As on 29 November 2020, total number of cases was 4704, including 106 active cases, 4537 cures and 61 fatalities.[3]

• As on 3 December 2020, total number of cases in Andaman and Nicobar Islands was 4729. There are 71 active cases, 4597 recoveries and 61 have died.[3]
• As on 5 December 2020, total number of cases was 4747. There are 70 active cases, 4616 cures and 61 have died.[3]
• As on 13 December 2020, total number of cases was 4818. There are 84 active cases, 4673 cures and 61 fatalities.[3]
• As on 15 December 2020, total number of cases was 4842, including 93 active cases, 4688 recoveries and 61 fatalities.[3]
• As on 20 December 2020, total number of cases was 4881, including 88 active cases, 4732 recoveries and 61 deaths.[3]
• As on 22 December 2020, total number of cases was 4893, including 82 active cases, 4749 recoveries and 62 deaths.[3]
• As on 23 December 2020, total number of cases was 4896, including 73 active cases, 4761 cures and 62 deaths.[3]
• As on 27 December 2020, total number of cases was 4924, including 64 active cases, 4798 cures and 62 fatalities.[3]
• As on 31 December 2020, total number of cases in the UT was 4945, including 57 active cases, 4826 cures and 62 fatalities.[3]

• As on 5 January, total number of cases in Andaman and Nicobar Islands was 4949. There are 31 active cases, 4856 recoveries and 62 deaths.[3]
• As on 10 January, total number of cases was 4960, including 23 active cases, 4875 cures and 62 deaths.[3]
• As on 18 January, total number of cases was 4988, including 29 active cases, 4897 recoveries and 62 fatalities.[3]
• As on 19 January, total number of cases was 4989, including 30 active cases, 4897 recoveries and 62 fatalities.[3]
• As on 24 January, total number of cases in the UT was 4993, including 23 active cases, 4908 recoveries and 62 deaths.[3]
• As on 28 January, total number of cases was 4994, including 8 active cases, 4924 recoveries and 62 fatalities.[3] The total number of active cases went below 10 for the first time since April 2020.

• As on 1 February, total number of cases in Andaman and Nicobar Islands was 4994. including 4932 recoveries and 62 deaths.[3] For the first time since March 2020, there wasn't any active case in the UT.

On January 1 2021, the Drug Controller General of India, approved the emergency or conditional use of AstraZeneca’s COVID-19 vaccine AZD1222 (marketed as Covishield).[4] Covishield is developed by the University of Oxford and its spin-out company, Vaccitech.[5] It's a viral vector vaccine based on replication-deficient Adenovirus that causes cold in Chimpanzees. It can be stored, transported and handled at normal refrigerated conditions (two-eight degrees Celsius/ 36-46 degrees Fahrenheit). It has a shelf-life of at least six months.

On 12 January, 2021 first batches of Covishield vaccine was despatched from the Serum Institute of India.[6]

On January 2, 2021, BBV152 (marketed as Covaxin), first indigenous vaccine, developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology received approval from the Drug Controller General of India for its emergency or conditional usage.[7]

On 14 January, 2021 first batches of Covaxin vaccine was despatched from the Bharat Biotech, albeit it was still in the third phase of testing.[8]